Fundraising Fox
Cytomos
4 known investors
Find your way into Cytomos
Sign up to see every warm intro you have to Cytomos
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cytomos team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Cytomos develops AuraCyt®, a microelectronics-based biotechnology platform for real-time single-cell analytics in bioprocessing and cell and gene therapy manufacturing. The company serves large biotech and pharma companies seeking cost-effective process analytical technology solutions for drug development and manufacturing.
Investors · 4
Archangelslisted by ArchangelsEdinburgh
How we know: a partner's Signal profile · funding news · Not right? Tell us
British Business BankreportedSheffield
How we know: funding news · Not right? Tell us
Old College CapitalreportedEdinburgh · $190.5K
How we know: funding news · Not right? Tell us
Scottish EnterprisereportedGlasgow
How we know: funding news · Not right? Tell us
Frequently asked questions
- What does Cytomos do?
- Cytomos develops AuraCyt®, a microelectronics-based biotechnology platform for real-time single-cell analytics in bioprocessing and cell and gene therapy manufacturing. The company serves large biotech and pharma companies seeking cost-effective process analytical technology solutions for drug development and manufacturing.
- Who are Cytomos's investors?
- Cytomos's investors include Archangels, British Business Bank, Old College Capital, Scottish Enterprise.